Acquired Peripheral Neuropathy: A Report on 20 Children
Open Access
- 1 April 2012
- journal article
- letter
- Published by SAGE Publications in International Journal of Immunopathology and Pharmacology
- Vol. 25 (2), 513-517
- https://doi.org/10.1177/039463201202500222
Abstract
Guillain—Barré syndrome (GBS) is an inflammatory polyneuropathy characterized by acute onset, rapid progression, symmetric muscular weakness, pain, and paresthesias. The incidence of GBS in the pediatric age group is 0.8 cases per 100,000; 50%-70% of the cases are preceded by respiratory or gastrointestinal infectious episodes or vaccination. The etiopathogenesis of GBS has been hypothesized to involve a direct immune-mediated mechanism against the peripheral nerves. A series of 20 patients managed in the Department of Pediatrics of the University of Catania between 2003 and 2011 and evaluated according to epidemiologic, clinical, and therapeutic features is reported.Keywords
This publication has 8 references indexed in Scilit:
- Clinical Presentation and Course of Childhood Guillain-Barré Syndrome: A Prospective Multicentre StudyNeuropediatrics, 2007
- Infections and vaccinations preceding childhood Guillain-Barré syndrome: a prospective studyEuropean Journal of Pediatrics, 2006
- Electrophysiological subtypes and prognosis of childhood Guillain–Barré syndrome in JapanMuscle & Nerve, 2006
- Current Therapeutic Options in Severe Guillain-Barre?? SyndromeClinical Neuropharmacology, 2006
- Guillain-Barré syndromeThe Lancet, 2005
- Guillain–Barré syndrome in childhoodJournal of Paediatrics and Child Health, 2005
- Acute motor axonal neuropathy after Mycoplasma infectionNeurology, 2004
- Assessment of current diagnostic criteria for Guillain-Barr syndromeAnnals of Neurology, 1990